Critical Illness Polyneuropathy
10
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Critical Illness Weakness Outside the Intensive Care Unit.
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Improved Recovery of Walking in Acquired Muscle Weakness
CPAx: Responsiveness and Minimal Clinically Important Difference
Evaluation of the NeuroMuscular Junction Using the Single Fiber Electromyography and Reliability of Train-Of-Four in Critically Ill Patients.
Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma
In-Bed Cycling in ICU Patients Post Cardiac Surgery
Validation of Simplified Electrophysiological Examination in the Diagnosis of Critical Illness Myopathy or Neuropathy
Effects of Early Stepping Verticalization + FES on CIP
Evaluation of Pediatric Critical Illness Neuropathy/Myopathy in Pediatric Intensive Care Unit